STUDIES OF PRIMARY IMMUNODEFICIENCY DISEASES
原发性免疫缺陷疾病的研究
基本信息
- 批准号:3768849
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The aim of this project is to define the immunopathogenetic mechanisms
responsible for human immunodeficiency syndromes. During the past year
we have focused on the functional capacities of T and B cells from
patients with common variable immunodeficiency (CVI). In studies of CVI
patient T cells, we showed that while purified CD4 T cells proliferate
normally in response to proliferation by PHA, staphylococcal enterotoxin
B (SEB) and anti-CD2 antibodies, these stimuli induce significantly less
IL-2 than normal CD4+ T cells. On the other hand, immobilized anti-CD3
antibody and this stimulus in combination with anti-CD28 antibody induced
CVI T cells to produce normal amounts of IL-2. These studies thus
demonstrate that the IL-2 production defect in CD4+ T cells is due to a
specific signalling pathway abnormality. In a second series of studies,
in this case focused on B cell function in CVI patients, we showed first
that circulating B cells express normal amounts of sIgM+, but greatly
reduced amounts of sIgG+ and sIgA+; this result implies that patients
have an in vivo defect of isotype switch differentiation. In other
studies, we showed that upon stimulation of purified patient B cells with
anti-CD40 antibody plus IL-10, patient B cells expressed Cmu, Cgamma and
Calpha mRNA; furthermore, stimulation of cells with anti-CD40 plus IL-10,
followed by stimulation with activated T cells (which express the CD40
ligand), led to partial restoration of IgG and IgA synthesis. These
studies thus indicate that CVI B cells can be partially restored to
normal function in vitro, suggesting that the cells are not irreversibly
blocked from isotype and terminal differentiation.
本项目的目的是明确免疫发病机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W STROBER其他文献
W STROBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W STROBER', 18)}}的其他基金
REGULATION OF IMMUNE RESPONSES IN HUMANS AND NON-HUMAN PRIMATES
人类和非人类灵长类动物免疫反应的调节
- 批准号:
3768794 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF MUCOSAL IMMUNE RESPONSES IN HUMANS AND NON-HUMAN PRIMATES
人类和非人类灵长类动物粘膜免疫反应的调节
- 批准号:
3790755 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF IMMUNE RESPONSES IN HUMANS AND NON-HUMAN PRIMATES
人类和非人类灵长类动物免疫反应的调节
- 批准号:
2566773 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF IMMUNE RESPONSES IN HUMANS AND NON-HUMAN PRIMATES
人类和非人类灵长类动物免疫反应的调节
- 批准号:
5200470 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




